Abbisko Cayman Ltd. - B: insider trades · Hong Kong · HKEX HKEX:abbisko-cayman-ltd-b HK HK · HKEX Mcap 6.8Bn€ Healthcare
Discover the full insider trade history of Abbisko Cayman Ltd. - B, a publicly traded company based in Hong Kong. Shares are quoted on HK HK, under the authority of HKEX. Operating in the Healthcare sector, Abbisko Cayman Ltd. - B has recorded 6 reports. Market capitalisation: €6.8bn. The latest transaction was disclosed on 10 April 2026 — Sale. Among the most active insiders: JI JING. The full history is free.
€373,485
6 ops.
Sell Volume
Financial data FY ended December 2025 · cache
Analyst consensus
7 analysts 20.40 € Target 22.95 €(+123%) 25.51 €
Income statement
Revenue 612.1 M€
Gross profit 612.1 M€ 100% margin
Net income 55.2 M€ 9.0% margin
Valuation
PER (trailing) 102.8x
PER (forward) -47.6x
P/Book 3.1x
Beta 1.26
Balance sheet & cash
Market cap 6.82 Bn€
Total debt 303.5 M€
Free Cash Flow 73.8 M€
Debt / Equity 16%
Profitability & ownership
ROE 2.8%
ROA 0.8%
% insiders 18.6%
% institutions 26.9%
Last declaration on 10 April 2026
Declarations 6 total
Executives ● Sale11 HKEX
€86,682 60,000 shares @ €1.4447 0.0013% mcap 42.8% of flow
HKEX:DA20260409E00481 · 2 Apr 2026
Executives ● Sale9 HKEX
€31,495 22,000 shares @ €1.4316 0.0005% mcap 15.6% of flow
HKEX:DA20260409E00480 · 2 Apr 2026
Executives ● Sale11 HKEX
€84,215 60,000 shares @ €1.4036 0.0012% mcap 41.6% of flow
HKEX:DA20260409E00418 · 1 Apr 2026
Executives ● Sale8 HKEX
€8,711 6,000 shares @ €1.4518 0.0001% mcap 5.1% of flow
HKEX:DA20260409E00464 · 8 Apr 2026
Executives ● Sale9 HKEX
€36,431 25,000 shares @ €1.4572 0.0005% mcap 21.3% of flow
HKEX:DA20260409E00463 · 2 Apr 2026
Executives ● Sale14 HKEX
€125,952 90,000 shares @ €1.3995 0.0018% mcap 73.6% of flow
HKEX:DA20260409E00420 · 1 Apr 2026